Jubilant Pharmova Ltd (BOM:530019)
₹ 1206.6 33.4 (2.85%) Market Cap: 191.07 Bil Enterprise Value: 218.08 Bil PE Ratio: 34.83 PB Ratio: 3.53 GF Score: 78/100

Q1 2020 Jubilant Life Sciences Ltd Earnings Call Transcript

Jul 26, 2019 / 11:30AM GMT
Release Date Price: ₹333.61 (-0.22%)
Operator

Good day, ladies and gentlemen, and a very warm welcome to the Jubilant Life Sciences Q1 FY '20 Earnings Conference Call. (Operator Instructions)

Please note that this conference is being recorded.

I now hand the conference over to Mr. Ravi Agrawal, Head of Investor Relations at Jubilant Life Sciences Limited. Thank you, and over to you, sir.

Ravi Agrawal
Jubilant Life Sciences Limited - Head of IR

Good evening, everybody. I'm Ravi Agrawal, Head of Investor Relations at Jubilant Life Sciences. I thank you again for being with us today on our Q1 FY '20 earnings conference call.

I would like to remind you that some of the statements made on the call today could be forward looking in nature, and a detailed disclaimer in this regard has been included in the press release that has been shared on our website.

On the call today, we have Mr. Shyam Bhartia, Chairman; Mr. Hari S. Bhartia, Co-Chairman and Managing Director; Mr. R. Sankaraiah, Executive Director of Finance; Mr. Pramod Yadav, CEO, Jubilant Pharma; Mr. Rajesh

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot